What is it about?
SGLT2 inhibitors are commonly used in clinical practice. Despite the mechanism of action of this drug class, there are only rare instances of potassium disturbances. This article reviews the various ways these drugs affect kidney potassium handling.
Featured Image
Read the Original
This page is a summary of: SGLT2 Inhibition and Kidney Potassium Homeostasis, Clinical Journal of the American Society of Nephrology, August 2023, Wolters Kluwer Health,
DOI: 10.2215/cjn.0000000000000300.
You can read the full text:
Contributors
The following have contributed to this page
